首页> 美国卫生研究院文献>other >Lactate normalization within 6 hours of bundle therapy and 24 hours of delayed achievement were associated with 28-day mortality in septic shock patients
【2h】

Lactate normalization within 6 hours of bundle therapy and 24 hours of delayed achievement were associated with 28-day mortality in septic shock patients

机译:感染性休克患者在捆绑治疗的6小时内乳酸正常化和延迟完成24小时与28天死亡率相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study evaluated the prognostic ability of lactate normalization achieved within 6 and 24 h from septic shock recognition. Data from a septic shock registry from October 2015 to February 2017 were reviewed. The study included 2,102 eligible septic shock patients to analyze the prognostic ability of lactate normalization, defined as a follow-up lactate level <2 mmol/L within six hours of bundle therapy and within 24 hours of delayed normalization. The primary outcome was 28-day mortality. The overall 28-day mortality rate was 21.4%. The rates of lactate normalization within 6 and 24 h were significantly higher in the survivor groups than in the non-survivor group (42.4% vs. 23.4% and 60.2% vs. 31.2%; P<0.001, respectively). Multivariate logistic regression analysis showed that both 6- and 24-h lactate normalization were independent predictors (odds ratio [OR] 0.58, 95% confidence interval [CI] 0.45–0.75, p<0.001 and OR 0.42, 95% CI 0.33–0.54, p<0.001, respectively). When we could not achieve the lactate normalization, the sensitivity, specificity, positive, and negative predictive value to predict mortality were 76.6%, 42.4%, 26.5% and 87.0% respectively for 6-h normalization, and 68.8%, 60.2%, 32.0% and 87.7% respectively for 24-h normalization. Besides 6-h lactate normalization, 24-h delayed lactate normalization was associated with decreasing mortality in septic shock patients. Lactate normalization may have a role in early risk stratification and as a therapeutic target.
机译:这项研究评估了败血性休克识别后6到24小时内乳酸正常化的预后能力。我们审查了2015年10月至2017年2月败血症性休克登记处的数据。该研究纳入了2102名合格的败血性休克患者,以分析乳酸正常化的预后能力,定义为捆绑治疗后6小时内和延迟正常化后24小时内乳酸水平<2 mmol / L。主要结局为28天死亡率。 28天的总死亡率为21.4%。幸存者组在6和24小时内的乳酸正常化率显着高于非幸存者组(分别为42.4%对23.4%和60.2%对31.2%; P <0.001)。多元logistic回归分析显示6小时和24小时乳酸正常化都是独立的预测因素(赔率[OR] 0.58,95%置信区间[CI] 0.45–0.75,p <0.001和OR 0.42,95%CI 0.33–0.54 ,分别为p <0.001)。当我们无法实现乳酸标准化时,对于6小时标准化,预测死亡率的敏感性,特异性,阳性和阴性预测值分别为76.6%,42.4%,26.5%和87.0%,以及68.8%,60.2%,32.0和82.0%。 24小时归一化分别为%和87.7%。除6小时乳酸正常化外,24小时延迟乳酸正常化还与败血性休克患者的死亡率降低相关。乳酸正常化可能在早期风险分层中发挥作用,并作为治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号